Last reviewed · How we verify

NCT06164067

The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination

Completed Last updated 11 December 2023
What this trial tests

trial testing abortus within 24 hours or 24-48 hours in Second Trimester Abortion in 136 participants. Completed in 15 August 2022.

Timeline
15 February 2022
Primary endpoint
15 August 2022
15 August 2022

Quick facts

Lead sponsorSanliurfa Mehmet Akif Inan Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment136
Start date15 February 2022
Primary completion15 August 2022
Estimated completion15 August 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Who can join

Adults 18 to 45, female only, with Second Trimester Abortion or Uterocervical Angle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the investigator study is the success of predictivity cervical consistency index (CCI), anterior uterocervical angle (aUCA) and posterior uterocervical angle (pUCA) in second trimester terminations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Second Trimester Abortion

Currently open trials in the same condition.

Other Sanliurfa Mehmet Akif Inan Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06164067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing